{"organizations": [], "uuid": "9438f645827b4cb8e19695b4d5bea176ef25e0ee", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180402.html", "section_title": "Archive News &amp; Video for Monday, 02 Apr 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-myriad-receives-pre-market-approva/brief-myriad-receives-pre-market-approval-for-its-bracanalysis-diagnostic-system-in-japan-idUSFWN1RF067", "country": "US", "domain_rank": 408, "title": "BRIEF-Myriad Receives Pre Market Approval For Its Bracanalysis Diagnostic System In Japan", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 1.0, "site_type": "news", "published": "2018-04-02T19:39:00.000+03:00", "replies_count": 0, "uuid": "9438f645827b4cb8e19695b4d5bea176ef25e0ee"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-myriad-receives-pre-market-approva/brief-myriad-receives-pre-market-approval-for-its-bracanalysis-diagnostic-system-in-japan-idUSFWN1RF067", "ord_in_thread": 0, "title": "BRIEF-Myriad Receives Pre Market Approval For Its Bracanalysis Diagnostic System In Japan", "locations": [], "entities": {"persons": [], "locations": [{"name": "japan", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "astrazeneca", "sentiment": "negative"}, {"name": "merck", "sentiment": "negative"}, {"name": "myriad genetics inc", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 2 (Reuters) - Myriad Genetics Inc - ‍Astrazeneca And Merck Are Seeking Approval Of Lynparza In Japan For Treating Patients With Brca :\n* MARKET APPROVAL FOR ITS BRACANALYSIS® DIAGNOSTIC SYSTEM IN JAPAN\n* MUTATED METASTATIC BREAST CANCER​ Source text for Eikon: Further company coverage:\n ", "external_links": ["https://twitter.com/reuters", "https://www.youtube.com/user/ReutersVideo", "https://www.linkedin.com/company/10256858/", "https://www.facebook.com/Reuters", "https://www.thomsonreuters.com/en/privacy-statement.html", "http://thomsonreuters.com/en/about-us/trust-principles.html", "https://instagram.com/reuters/"], "published": "2018-04-02T19:39:00.000+03:00", "crawled": "2018-04-03T16:05:58.123+03:00", "highlightTitle": ""}